|
1
|
Hackeng WM, Hruban RH, Offerhaus GJ and
Brosens LA: Surgical and molecular pathology of pancreatic
neoplasms. Diagn Pathol. 11:472016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martinez-Useros J and Garcia-Foncillas J:
Can molecular biomarkers change the paradigm of pancreatic cancer
prognosis? Biomed Res Int 2016. 48730892016.
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abreu FB, Liu X and Tsongalis GJ: miRNA
analysis in pancreatic cancer: The Dartmouth experience. Clin Chem
Lab Med. 55:755–762. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chari ST: Detecting early pancreatic
cancer: Problems and prospects. Semin Oncol. 34:284–294. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Z, Li Y, Ahmad A, Banerjee S, Azmi
AS, Kong D and Sarkar FH: Pancreatic cancer: Understanding and
overcoming chemoresistance. Nat Rev Gastroenterol Hepatol. 8:27–33.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McCann MJ, Rotjanapun K, Hesketh JE and
Roy NC: Expression profiling indicating low selenium-sensitive
microRNA levels linked to cell cycle and cell stress response
pathways in the CaCo-2 cell line. Br J Nutr. 117:1212–1221. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lizarbe MA, Calle-Espinosa J,
Fernandez-Lizarbe E, Fernández-Lizarbe S, Robles MÁ, Olmo N and
Turnay J: Colorectal cancer: From the genetic model to
posttranscriptional regulation by noncoding RNAs. Biomed Res Int.
2017:73542602017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Narouie B, Ziaee SAM, Basiri A and Hashemi
M: Functional polymorphism at the miR-502-binding site in the 3′
untranslated region of the SETD8 gene increased the risk of
prostate cancer in a sample of Iranian population. Gene.
626:354–357. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
D'Angelo B, Benedetti E, Cimini A and
Giordano A: MicroRNAs: A puzzling tool in cancer diagnostics and
therapy. Anticancer Res. 36:5571–5575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fukuda M, Kanno E, Ishibashi K and Itoh T:
Large scale screening for novel rab effectors reveals unexpected
broad rab binding specificity. Mol Cell Proteomics. 7:1031–1042.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baldini G, Hohl T, Lin HY and Lodish HF:
Cloning of a rab3 isotype predominantly expressed in adipocytes.
Proc Natl Acad Sci USA. 89:5049–5052. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lutcke A, Jansson S, Parton RG, Chavrier
P, Valencia A, Huber LA, Lehtonen E and Zerial M: Rab17, a novel
small GTPase, is specific for epithelial cells and is induced
during cell polarization. J Cell Biol. 121:553–564. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tisdale EJ, Bourne JR, Khosravi-Far R, Der
CJ and Balch WE: GTP-binding mutants of rab1 and rab2 are potent
inhibitors of vesicular transport from the endoplasmic reticulum to
the golgi complex. J Cell Biol. 119:749–761. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Culine S, Honore N, Closson V, Droz JP,
Extra JM, Marty M, Tavitian A and Olofsson B: A small GTP-binding
protein is frequently overexpressed in peripheral blood mononuclear
cells from patients with solid tumours. Eur J Cancer. 30A:1–674.
1994.PubMed/NCBI
|
|
16
|
Alma DC, Gerardo CM, Abraham PT, Romo RV,
Reyes FIP, López-Urrutia E and Pérez-Plasencia C: Micro-RNAs as
potential predictors of response to breast cancer systemic therapy:
Future clinical implications. Int J Mol Sci.
18:E11282017.PubMed/NCBI
|
|
17
|
Mandujano-Tinoco EA, Garcia-Venzor A,
Munoz-Galindo L, Lizarraga-Sanchez F, Favela-Orozco A,
Chavez-Gutierrez E, Krötzsch E, Salgado RM, Melendez-Zajgla J and
Maldonado V: miRNA expression profile in multicellular breast
cancer spheroids. Biochim Biophy Acta. 1864:1642–1655. 2017.
View Article : Google Scholar
|
|
18
|
Eichmuller SB, Osen W, Mandelboim O and
Seliger B: Immune modulatory microRNAs involved in tumor attack and
tumor immune escape. J Natl Cancer Inst. 109:2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
van Rooij E and Olson EN: MicroRNA
therapeutics for cardiovascular disease: Opportunities and
obstacles. Nat Rev Drug Discov. 11:860–872. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kyrychenko S, Kyrychenko V, Badr MA, Ikeda
Y, Sadoshima J and Shirokova N: Pivotal role of miR-448 in the
development of ROS-induced cardiomyopathy. Cardiovasc Res.
108:324–334. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qin X, Wang J, Wang X, Liu F, Jiang B and
Zhang Y: Targeting rabs as a novel therapeutic strategy for cancer
therapy. Drug Discov Today. 22:1139–1147. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dong Q, Fu L, Zhao Y, Du Y, Li Q, Qiu X
and Wang E: Rab11a promotes proliferation and invasion through
regulation of YAP in non-small cell lung cancer. Oncotarget.
8:27800–27811. 2017.PubMed/NCBI
|
|
23
|
Gu L, Gao J, Li Q, Zhu YP, Jia CS, Fu RY,
Chen Y, Liao QK and Ma Z: Rapamycin reverses NPM-ALK-induced
glucocorticoid resistance in lymphoid tumor cells by inhibiting
mTOR signaling pathway, enhancing G1 cell cycle arrest and
apoptosis. Leukemia. 22:2091–2096. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shankland SJ, Hugo C, Coats SR, Nangaku M,
Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG and Johnson
RJ: Changes in cell-cycle protein expression during experimental
mesangial proliferative glomerulonephritis. Kidney Int.
50:1230–1239. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang D and Brodt P: Type 1 insulin-like
growth factor regulates MT1-MMP synthesis and tumor invasion via PI
3-kinase/Akt signaling. Oncogene. 22:974–982. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Roy HK, Olusola BF, Clemens DL, Karolski
WJ, Ratashak A, Lynch HT and Smyrk TC: AKT proto-oncogene
overexpression is an early event during sporadic colon
carcinogenesis. Carcinogenesis. 23:201–205. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cinti C, Vindigni C, Zamparelli A, La Sala
D, Epistolato MC, Marrelli D, Cevenini G and Tosi P: Activated Akt
as an indicator of prognosis in gastric cancer. Virchows Arch.
453:449–455. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li JC, Zhu HY, Chen TX, Zou LY, Wang XY,
Zhao HC and Xu J: Roles of mTOR and p-mTOR in gastrointestinal
stromal tumors. Asian Pac J Cancer Prev. 14:5925–5928. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pastor MD, Garcia-Yebenes I, Fradejas N,
Pérez-Ortiz JM, Mora-Lee S, Tranque P, Moro MA, Pende M and Calvo
S: mTOR/S6 kinase pathway contributes to astrocyte survival during
ischemia. J Biol Chem. 284:22067–22078. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Colell A, Ricci JE, Tait S, Milasta S,
Maurer U, Bouchier-Hayes L, Fitzgerald P, Guio-Carrion A,
Waterhouse NJ, Li CW, et al: GAPDH and autophagy preserve survival
after apoptotic cytochrome c release in the absence of caspase
activation. Cell. 129:983–997. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schreiber V, Amé JC, Dollé P, Schultz I,
Rinaldi B, Fraulob V, Ménissier-de Murcia J and de Murcia G:
Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient
base excision DNA repair in association with PARP-1 and XRCC1. J
Biol Chem. 277:23028–23036. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Haince JF, Rouleau M, Hendzel MJ, Masson
JY and Poirier GG: Targeting poly(ADP-ribosyl)ation: A promising
approach in cancer therapy. Trends Mol Med. 11:456–463. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tormanen-Napankangas U, Soini Y, Kahlos K,
Kinnula V and Paakko P: Expression of caspases-3, −6 and −8 and
their relation to apoptosis in non-small cell lung carcinoma. Int J
Cancer. 93:192–198. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cho BB and Toledo-Pereyra LH:
Caspase-independent programmed cell death following ischemic
stroke. J Invest Surg. 21:141–147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moroni F: Poly(ADP-ribose)polymerase 1
(PARP-1) and postischemic brain damage. Curr Opin Pharmacol.
8:96–103. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
van Wijk SJ and Hageman GJ:
Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell
death after ischemia/reperfusion. Free Radic Biol Med. 39:81–90.
2005. View Article : Google Scholar : PubMed/NCBI
|
